[home]
[thesaurus]
Click Here to return To Results
Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab
NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021
See this aricle in Pubmed
Article Abstract
No abstract available for this article
Related Tags
(click to filter results - removes previous filter)
aducanumab
Alzheimer's disease
Alzheimer's disease,treatment of
amyloid beta protein
amyloid beta protein antibodies
amyloid-related imaging abnormalities
biologic markers
CAT scan,emission,abnormal
cerebral edema,vasogenic
complications
contraindications
controversies in neurology
cost
microhemorrhage,intracerebral
mild cognitive impairment
monoclonal antibodies
shared decision making
treatment of neurologic disorder
Click Here to return To Results